Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Other Chemical Drugs > Abaloparatide for Sale > Abaloparatide Acetate, Abaloparatide, Abaloparatide Acetate Salt, Abaloparatide Acetate API, Abaloparatide Acetate Peptide, Peptide
Abaloparatide Acetate, Abaloparatide, Abaloparatide Acetate Salt, Abaloparatide Acetate API, Abaloparatide Acetate Peptide, Peptide buy - large image1
Abaloparatide Acetate, Abaloparatide, Abaloparatide Acetate Salt, Abaloparatide Acetate API, Abaloparatide Acetate Peptide, Peptide buy - image1
Abaloparatide Acetate, Abaloparatide, Abaloparatide Acetate Salt, Abaloparatide Acetate API, Abaloparatide Acetate Peptide, Peptide buy - image2
Abaloparatide Acetate, Abaloparatide, Abaloparatide Acetate Salt, Abaloparatide Acetate API, Abaloparatide Acetate Peptide, Peptide buy - image3

Abaloparatide Acetate, Abaloparatide, Abaloparatide Acetate Salt, Abaloparatide Acetate API, Abaloparatide Acetate Peptide, Peptide

GMP FDA COA 40 Inquiries

Unit Price: Get Latest Price
CAS No.:

247062-33-5

Grade:

Pharmaceutical Grade

Content:

99%

Port:

Chengdu

Brand:

Chengdu Shengnuo, Shengnuo Biopharm

Packaging:

g

Price valid (until):

2025-11-15

Company Type:
Manufactory
Location:
China
Qualification:
Main Products:

Semaglutide API,Tirzepatide API,Liraglutide API,Linaclotide API,Creatine Monohydrate,Copper Tripeptide-1

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Abaloparatide Acetate, Abaloparatide, Abaloparatide Acetate Salt, Abaloparatide Acetate API, Abaloparatide Acetate Peptide, Peptide

     

    CAS No.:   247062-33-5

    Purity: ≥99% (HPLC)
    Molecular Formula: C 174 H 267 N 55 O 51 ·xC 2 H 4 O 2 (x=3-5)

    Theoretical Molecular Weight: 3961.4 Da (free base)
    Appearance: White to off-white lyophilized powder
    Storage  Conditions : -20°C±5°C (dry, protected from light)
    Sequence: Ala-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe (PTHrP 1-34 analog)
    Solubility: Solubility in H2O : 25 mg/mL Solubility in DMSO : 12.1 mg/mL

     

    Indications

    1. For postmenopausal osteoporosis (PMO).
    2. For male osteoporosis (FDA-approved in 2022).

     

    Certificates

    Basic Info
    Product Name:

    Abaloparatide

    Other Name:

    Abaloparatide;Abaloparatide (BA058)

    CAS No.:

    247062-33-5

    Molecular Formula:

    C174H300N56O49

    InChIKeys:

    BVISQZFBLRSESR-XSCWXTNMSA-N

    Molecular Weight:

    3960.5896

    EC Number:

    218-362-5

    Color/Form:

    White to off-white

    Categories:

    Other Chemical Drugs

    Characteristics
  • Seller Information
    Business Type:

    Manufactory

    Main Products:

    Semaglutide API,Tirzepatide API,Liraglutide API,Linaclotide API,Creatine Monohydrate,Copper Tripeptide-1

    Location:

    Chengdu Shengnuo Biopharm Co., Ltd.

    Payment Terms:

    TT against copy of documents,D/P,L/C,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    365

    Total Annual Revenue:

    Above $100 million

    Total Employees:

    Above 1000

    Year of Establishment:

    2004

  • Inquiry History
    40 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Abaloparatide – Sequence length: 34 amino acids

    10 MG Aug 15, 2025
    United Kingdom

    Abaloparatide

    10 G Dec 18, 2025
    Canada

    Abaloparatide

    16 G Jun 14, 2026
    Czech

    abaloparatide

    1000 MG Jun 12, 2026
    Netherlands

    Abaloparatide

    50 MG Jun 5, 2026
    Australia

    Ablopartide

    10 MG May 24, 2026
    United States

    abaloparatide

    May 21, 2026
    United States

    Abaloparatide

    10  Apr 18, 2026
    United States

    Abaloparatide

    Mar 19, 2026
    United Kingdom

    Abaloparatide

    1 PCS Mar 18, 2026
    United States

    Abaloparatide

    10 G Mar 13, 2026
    Sweden

    Abaloparatide

    1 KG Dec 30, 2025
    United States

    abaloparatide-cas247062

    100 MG Jun 3, 2026
    United States

    Abaloparatide

    Jun 3, 2026
    United States

    abaloparatide

    1 G May 23, 2026
    United States

    Abaloparatide

    100 MG May 20, 2026
    United States

    Abaloparatide

    1 G Mar 24, 2026
    United States

    Abaloparatide

    30 G Mar 19, 2026
    United Kingdom

    Abaloparatide

    1 G Mar 18, 2026
    United States

    usa warehouse Abaloparatide 99% white powder

    10 MG Feb 5, 2026
    • 1
    • 2
    • Go to Page Go
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.